Literature DB >> 34112654

Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort'.

Jesse Veenstra1,2,3, Jie Wang1,2,3, Kathleen McKinnon-Maksimowicz4, Tingting Liu1,2,3, Bobby Zuniga1,2,3, Iltefat Hamzavi1, Li Zhou1,2,3, Qing-Sheng Mi5,2,3.   

Abstract

Entities:  

Keywords:  COVID-19; autoimmune diseases; immune system diseases; vaccination

Year:  2021        PMID： 34112654     DOI： 10.1136/annrheumdis-2021-220736

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1. 

Authors:  Maxime Auroux; Benjamin Laurent; Baptiste Coste; Emmanuel Massy; Alexandre Mercier; Isabelle Durieu; Cyrille B Confavreux; Jean-Christophe Lega; Sabine Mainbourg; Fabienne Coury
Journal:  Rev Rhum Ed Fr       Date:  2022-07-08

2.  Guidelines on COVID-19 vaccination in patients with immune-mediated rheumatic diseases: a Brazilian Society of Rheumatology task force.

Authors:  Anna Carolina Faria Moreira Gomes Tavares; Ana Karla Guedes de Melo; Vítor Alves Cruz; Viviane Angelina de Souza; Joana Starling de Carvalho; Ketty Lysie Libardi Lira Machado; Lilian David de Azevedo Valadares; Edgard Torres Dos Reis Neto; Rodrigo Poubel Vieira de Rezende; Maria Fernanda Brandão de Resende Guimarães; Gilda Aparecida Ferreira; Alessandra de Sousa Braz; Rejane Maria Rodrigues de Abreu Vieira; Marcelo de Medeiros Pinheiro; Sandra Lúcia Euzébio Ribeiro; Blanca Elena Gomes Rios Bica; Kátia Lino Baptista; Izaias Pereira da Costa; Claudia Diniz Lopes Marques; Maria Lúcia Lemos Lopes; José Eduardo Martinez; Rina Dalva Neubarth Giorgi; Lícia Maria Henrique da Mota; Marcos Antônio Araújo da Rocha Loures; Eduardo Dos Santos Paiva; Odirlei André Monticielo; Ricardo Machado Xavier; Adriana Maria Kakehasi; Gecilmara Cristina Salviato Pileggi
Journal:  Adv Rheumatol       Date:  2022-01-17

3.  COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study.

Authors:  George E Fragoulis; Vassiliki-Kalliopi Bournia; Eugenia Mavrea; Gerasimos Evangelatos; Kalliopi Fragiadaki; Anastasios Karamanakos; Eyrydiki Kravariti; Katerina Laskari; Stylianos Panopoulos; Maria Pappa; Dimos D Mitsikostas; Maria G Tektonidou; Dimitrios Vassilopoulos; Petros P Sfikakis
Journal:  Rheumatol Int       Date:  2021-11-05       Impact factor: 2.631

Review 4.  COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations.

Authors:  Rebecca Grainger; Alfred H J Kim; Richard Conway; Jinoos Yazdany; Philip C Robinson
Journal:  Nat Rev Rheumatol       Date:  2022-02-25       Impact factor: 32.286
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.